Review
Candidate gene studies in gallbladder cancer: A systematic review and meta-analysis

https://doi.org/10.1016/j.mrrev.2011.06.002Get rights and content

Abstract

Gallbladder cancer (GBC) is the most frequent biliary tract malignancy. Wide variations in GBC incidence and familial and epidemiological data suggest involvement of a genetic component in its etiopathogenesis. A systematic review of genetic association studies in GBC was performed by applying a meta-analysis approach and systematically reviewing PubMed database using appropriate terms. Odds ratios (ORs) and 95% confidence intervals (CIs) were appropriately derived for each gene–disease association using fixed and random effect models. Meta-regression with population size and genotyping method was also performed. Study quality was assessed using a 10-point scoring system designed from published guidelines. Following a review of 44 published manuscripts and one unpublished report, 80 candidate gene variants and 173 polymorphisms were analyzed among 1046 cases and 2310 controls. Majority of studies were of intermediate quality. Four polymorphisms with >3 separate studies were included in the meta-analysis [OGG1 (rs1052133), TP53 (rs1042522), CYP1A1 (rs1048943) and GSTM1 null polymorphism]. The meta-analysis demonstrated no significant associations of any of the above polymorphisms with GBC susceptibility except TP53 (rs1042522) polymorphism. To conclude, existing candidate gene studies in GBC susceptibility have so far been insufficient to confirm any association. Future research should focus on a more comprehensive approach utilizing potential gene–gene, gene–environment interactions and high-risk haplotypes.

Introduction

Gallbladder cancer (GBC) is the most frequent biliary tract malignancy and the fifth most common malignant neoplasm of the digestive tract [1]. Despite recent advances in the diagnosis and management of gastrointestinal cancers, GBC remains a challenging tumour with a poor overall prognosis. Many of these tumours are not resectable at the time of presentation, and the 5-year survival rate is <10% in most of the reported series [2]. GBC incidence varies greatly throughout the world, highest being in Native American and South American populations, and people from Poland and Northern India. Between 17,000 and 18,000 new cases of GBC are diagnosed in India each year, and the annual death rate is almost comparable [3]. The frequency increases with age and reaches to peak during the seventh and eighth decades of life [4]. GBC incidence also shows striking gender bias and affect females 2–3 times more frequently than males [4].

Several epidemiological studies have been conducted to estimate the effects of environmental factors on GBC risk to elucidate the large ethnic variations in risk [5], [6]. Yet, no single environmental factor has persistently been linked with GBC risk. It has been observed that Indian migrants to different countries have a higher risk of acquiring GBC as compared to the respective native populations [7]. Thus, the wide geographical, ethnic and interindividual variations observed in the incidence of GBC suggest the involvement of a genetic component in its etiopathogenesis.

The discovery of common genetic polymorphisms in human DNA has led to the publication of a large number of association studies in GBC [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [56]. However, a number of contradictory findings have been reported, and in several cases it has proved difficult to reproduce initial results. Also due to the high false positive associations, the possibility of a true association is well dependent on the quality of the studies concerned [31]. The major flaw with the individual studies is small sample sizes and therefore insufficient statistical power to detect positive associations and incapability to demonstrate the absence of an association. This necessitates the use of meta-analysis to provide an integrative approach by pooling the results of independent analyzes, thereby increasing statistical power and resolution [32], [33], [34], [35]. Thus, to get a better insight in the GBC pathogenesis, the present study was undertaken to explore the role of candidate gene polymorphisms in GBC susceptibility by applying a meta-analytical approach and systematically reviewing the available data.

Moreover, to draw a preliminary conclusion, we also carried out a systematic quality review of the published literature on genetic association studies in GBC. This was accomplished by strictly following the various guidelines and checklists that have been published on the conduct of genetic association studies in complex diseases [36], [37], [38], [39]. Using the criteria as described by Clark and Baudouin [40], we analyzed each publication to highlight the quality issues in the conduct and interpretation of these studies and also to establish if the existing data supports any polymorphism to be conclusively associated with GBC.

Section snippets

Literature search

Studies were selected by searching PubMed for articles listed from 2000 until March 2011 using the strategy outlined below:

  • 1.

    Restriction fragment length polymorphism/OR genetic polymorphism/OR single nucleotide polymorphism/OR DNA polymorphism/OR genetic variation.

  • 2.

    Genetic association/.

  • 3.

    Single nucleotide polymorphism/OR SNP.

  • 4.

    Gallbladder cancer/OR carcinoma of gallbladder/OR GBC.

  • 5.

    1 OR 2 OR 3.

  • 6.

    4 AND 5.

  • 7.

    Limit 6 to (Human and English language).

Titles and abstracts of articles found were screened, and full

Results

The PubMed search returned 52 unique articles of which 44 articles met the established inclusion criteria and were included in the analysis. Overall, these 44 articles investigated 80 candidate genes and 173 different polymorphisms in association with GBC. Fourteen studies investigated the role of gene–gene interactions in GBC susceptibility. Of the 80 genes studied, twenty five were involved in inflammatory pathway, eleven in DNA repair, twenty three in metabolic pathway, fifteen in hormonal

Discussion

Although there have been several descriptive reviews on this topic, to the best of authors’ knowledge, this is the first systematic review analyzing the effect of genetic determinants in GBC. In summary, we reviewed the available literature on genetic studies of GBC and conducted four independent meta-analyses for association between GBC and OGG1 rs1052133, TP53 rs1042522, GSTM1 and CYP1A1 rs1048943 polymorphisms. There was minimal evidence for a probable overall association between the studied

Conclusion

To conclude, although some genes show promise, the existing candidate gene studies in GBC susceptibility have so far been insufficient to confirm any association. The small number of studies decrease the potential generalization of results and also the statistical power [81], [82]. Thus, only preliminary conclusions can be drawn at this stage. Owing to its complex aetiology, it is extremely implausible that any single SNP or risk factor contributes significantly to the development of GBC in a

Conflict of interest

The authors declare that there are no conflicts of interest.

Acknowledgements

This research was supported [in part] by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (USA), Indian council of Medical Research (ICMR), DST and CSIR Government of India.

References (111)

  • A.E Stephen et al.

    Carcinoma in the porcelain gallbladder: a relationship revisited

    Surgery

    (2001)
  • U. Dutta et al.

    Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder

    Am. J. Gastroenterol.

    (2000)
  • D.M. Nagorney et al.

    Carcinoma of the gallbladder and extrahepatic bile ducts

    Semin. Oncol.

    (1988)
  • V. Dhir et al.

    Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas

    Indian J. Gastroenterol.

    (1999)
  • E.C. Lazcano-Ponce et al.

    Epidemiology and molecular pathology of gallbladder cancer

    CA Cancer J. Clin.

    (2001)
  • M. Pandey

    Environmental pollutants in gallbladder carcinogenesis

    J. Surg. Oncol.

    (2006)
  • M. Pandey et al.

    Diet and gallbladder cancer: a case–control study

    Eur. J. Cancer Prev.

    (2002)
  • V.K. Kapoor et al.

    Gallbladder cancer: an ‘Indian’ disease

    Natl. Med. J. India

    (2003)
  • A. Srivastava et al.

    Complement receptor 1(A3650G RsaI and Intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population

    Scand. J. Immunol.

    (2009)
  • A. Srivastava et al.

    CCR5 delta32 polymorphism: associated with gallbladder cancer susceptibility

    Scand. J. Immunol.

    (2008)
  • A. Srivastava et al.

    Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer

    J. Gastroenterol. Hepatol.

    (2008)
  • A. Srivastava et al.

    No association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer

    DNA Cell Biol.

    (2008)
  • A. Srivastava et al.

    Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population

    Ann. Surg. Oncol.

    (2009)
  • A. Srivastava et al.

    Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility

    Liver Int.

    (2009)
  • K. Srivastava et al.

    Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of northern India

    Cancer

    (2010)
  • K. Srivastava et al.

    Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population

    J. Gastroenterol.

    (2009)
  • S.K. Park et al.

    Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China

    Carcinogenesis

    (2009)
  • A.W. Hsing et al.

    Gallstones and the risk of biliary tract cancer: a population-based study in China

    Br. J. Cancer

    (2007)
  • A.W. Hsing et al.

    Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China

    Cancer Res.

    (2008)
  • S.N. Pandey et al.

    Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population

    Eur. J. Cancer Prev.

    (2008)
  • S.N. Pandey et al.

    Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility

    Int. J. Gastrointest. Cancer

    (2006)
  • S.N. Pandey et al.

    Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in north India

    Biomarkers

    (2006)
  • S.N. Pandey et al.

    Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease

    Cancer Biol. Ther.

    (2007)
  • S.N. Pandey et al.

    Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer

    Liver Int.

    (2007)
  • M. Vishnoi et al.

    Do TNFA-308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?

    Asian Pac. J. Cancer Prev.

    (2007)
  • Y. Isomura et al.

    A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer

    J. Gastroenterol.

    (2010)
  • S.J. Chanock et al.

    Replicating genotype–phenotype associations

    Nature

    (2007)
  • L.D. Cohn et al.

    How meta-analysis increases statistical power

    Psychol. Methods

    (2003)
  • M. Egger et al.

    Meta-analysis: principles and procedures

    BMJ

    (1997)
  • J.E. Hunter et al.

    Methods of Metaanalysis: Correcting Error and Bias in Research Findings

    (1990)
  • Anonymous

    Freely associating

    Nat. Genet.

    (1999)
  • S.T.J. Bogardus et al.

    Clinical epidemiological quality in molecular genetic research: the need for methodological standards

    JAMA

    (1999)
  • D.N Cooper et al.

    Proposed guidelines for papers describing DNA polymorphism-disease associations

    Hum. Genet.

    (2002)
  • M. Clark et al.

    A systematic review of the quality of genetic association studies in human sepsis

    Intensive Care Med.

    (2006)
  • S. Wacholder et al.

    Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

    J. Natl. Cancer Inst.

    (2004)
  • B. Woolf

    On estimating the relation between blood group and disease

    Ann. Hum. Genet.

    (1955)
  • A. Thakkinstian et al.

    A method for meta-analysis of molecular association studies

    Stat. Med.

    (2005)
  • T.A. Trikalinos et al.

    Impact of violations and deviations in Hardy–Weinberg equilibrium on postulated gene–disease associations

    Am. J. Epidemiol.

    (2006)
  • J.P. Ioannidis et al.

    Assessment of cumulative evidence on genetic associations: interim guidelines

    Int. J. Epidemiol.

    (2008)
  • Y. Tsuchiya et al.

    Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer

    J. Exp. Clin. Cancer Res.

    (2002)
  • Cited by (80)

    • The role of circadian gene timeless in gastrointestinal cancers

      2023, Gene Reports
      Citation Excerpt :

      By 2022, the number of new cases of gallbladder cancer in the United States is estimated at 12,130, and the number of deaths from this cancer is 4400 (Siegel et al., 2021). Risk factors for this disease depend on the lifestyle and genetics of individuals, including gender, obesity, cholelithiasis (Folseraas and Boberg, 2016), the presence of some bacterial infections such as S. typhi (Ferreccio, 2012; Soofiyani et al., 2021), biliary polyps, calcification of the gallbladder wall (Baiu and Visser, 2018), and the occurrence of polymorphisms in genes related to GBC (Srivastava et al., 2011). According to searches from multiple databases, no studies have been reported on TIM genes (such as the role of polymorphisms and mutations) and their role in gallbladder cancer.

    • Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies

      2021, Bulletin du Cancer
      Citation Excerpt :

      The c.1482-19A>G (rs3769818) variant was detected in 9/100 patients while the rest of 91 patients harbored the A allele. The A allele of this SNP was reported in association with the risk of developing breast cancer [32], esophageal squamous cell carcinoma [33,34] and Gallbladder Cancer [35–38]. This is consistent with our results since breast cancer was observed in 20.5% of our cases as associated with solid tumor and all of them had the A allele.

    • STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma

      2018, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      Gallbladder cancer (GBC) is the most commonly diagnosed malignancy of the biliary tract with an incidence of 2.5 in 100,000 individuals (Randi et al., 2006; Srivastava et al., 2011; Wu et al., 2014).

    View all citing articles on Scopus
    View full text